How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

The introduction of dynamic arrays triggered the biggest change to how we work with Microsoft Excel formulas in years, if not decades. They allow a single formula to spill multiple results into ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Natural selection uses duplicated genes as raw material for functional innovation, co-opting their existing features to new functions. Understanding genetic innovation requires two questions to be ...